Starmer's trade deals will do nothing to fix Britain's broken economy
Not only did the Bank of England announce an interest rate cut, perhaps with the prospect of more cuts to come, but the UK managed to secure trade agreements with India and the US. Is this the turning of the corner that both have been longing for?
The interest rate reduction, although welcome, is no game-changer. As I wrote last week, it has been possible simply because of the weakness of the economy. This hardly sets the economic pulse racing.
The two trade deals, although not completely surprising, are more newsworthy. Both are significant in relation to what they say about Brexit. It may seem incredible that nearly nine years after the Brexit vote, we are still debating whether the whole thing makes sense. But we are.
At the risk of going over old ground, let me make it clear that most of those economists who were in favour of Brexit, myself included, conceded that there were some losses to be borne from leaving the customs union and the single market.
Quite apart from the political factors, which many of us regarded as paramount, the essence of the economic case for Brexit was that there were two positive factors to lay beside the likely losses. The first of these was the ability to sign trade agreements with various countries around the world, and the second was the ability to break away from the stifling EU regulatory regime.
With regard to trade agreements, the Remainers argued that our prospects for securing good deals were slim because, as a medium-sized country, about the sixth- or seventh-largest in the world, we would carry very little clout compared to the EU, which is the second- or third-largest economy in the world, not that far behind the United States.
I never disputed this point. My argument always was that clout isn't everything. Indeed, there was a major factor offsetting clout, namely the ability actually to make an agreement.
Getting the EU to forge a trade deal with almost anybody was always going to be extremely difficult because it involved getting the agreement of 28 member countries, each of which had very different interests. Not to mention that one of those countries is France.
So the fact that we have managed to secure an agreement with India – already the world's fourth-largest economy, while the EU is still engaged in negotiations which may lead nowhere, was both revealing and amusing.
Much the same goes for the trade agreement we have managed to secure with the US.
Of course, there is the predictable carping from all the usual suspects about what damage will be done to our economy from opening ourselves up to imports from India and America.
We all know the old adage that there are only two inevitabilities in life, namely death and taxes. In fact, there are three. The third is opposition to tariff-free trade from producer groups, which fear competition from overseas.
Nevertheless, it has to be admitted that neither of these deals will dramatically enhance the UK economy. With a following wind, the Indian deal may increase UK GDP by something of the order of 0.1pc.
Although the US deal will give a major boost to the UK's car industry, the overall effect will be small because the trade deal's coverage is so limited. It stops well short of the full free trade agreement that has been on the table for several years, and is likely to remain there for several more, blocked by mounds of chlorinated chicken and hormone-treated beef.
Notwithstanding the possible gains from trade agreements, most Brexit-supporting economists argued that the main economic benefits of Brexit would be realised from breaking away from the EU's regulatory ambit.
Yet during the last Conservative government, there was next to no progress on this front and, unsurprisingly, there has been nothing from Labour. In fact, the travel has been in the opposite direction. Evidently, deregulation is 'difficult'.
But it is a sad fact of economic life that major economic gains are rarely to be had by doing the easy things. After some years of negotiations, it may seem that securing trade deals with India and the United States are one of the hard things.
I beg to differ. These are the easy things. Similarly, the looming 'reset' with the EU that Labour has been salivating over. It will bring scarcely any economic benefit to the UK and may even bring a net loss.
The really hard thing that would make a difference is to take a scythe to large parts of the public sector in order to be able to reduce taxes. Instead, the Government is about to pour more money into the NHS in order to raise doctors' pay.
The damage wrought by the increase in employers' National Insurance contributions and the large increases in the minimum wage would outweigh umpteen trade deals and any EU 're-set' combined.
Mind you, there is one easy thing to do. If the Government is serious about boosting the economy, and especially if it is serious about reviving manufacturing, there is actually a lever to pull, namely to radically postpone the rush to net zero and dramatically reduce the price of energy to both businesses and consumers.
One and a half cheers for the Government for securing these trade agreements. But on their own, they won't achieve much. Economic policy needs a complete change of direction.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
8 minutes ago
- Yahoo
Airbus workers to stage strikes amid pay dispute
Workers at aircraft manufacturer Airbus are to stage a series of strikes in a dispute over pay. Unite said around 3,000 of its members will walk out for 10 days in September after they voted overwhelmingly in favour of industrial action. Unite general secretary Sharon Graham said: 'Airbus is generating billions in profit; workers deserve a fair deal. Our members are simply seeking fairness not favours. 'Airbus workers have the total support of their union in this dispute.' Unite warned the strikes will hit production of wings for Airbus's commercial and military aircraft programmes.
Yahoo
8 minutes ago
- Yahoo
UK inflation rises to 18-month high in July, driven by higher air fares
Inflation jumped to its highest level in 18 months, amid higher food prices and transport costs. Figures from the Office for National Statistics (ONS) showed the annual rate as measured by the consumer price index (CPI) climbed to an unexpected 3.8% in July, up from 3.6% in June. It is forecast to reach 4% by the end of the year. Transport costs, mainly as a result of higher air fares, were the largest upward driver of prices. Petrol prices nudged higher compared with last year, when prices at the pumps were falling. Food and non-alcoholic drinks were up 4.9% year on year in July, an increase from 4.5% in the 12 months to June. ONS chief economist Grant Fitzner said air fares experienced the largest July increase since the agency began collecting that data on a monthly basis in 2001. 'This increase was likely due to the timing of this year's school holidays,' he said. It's the highest rate of price increases since January 2024, when annual inflation was 4%. "The price of petrol and diesel also increased this month, compared with a drop this time last year," he added. "Food price inflation continues to climb, with items such as coffee, fresh orange juice, meat and chocolate seeing the biggest rises." Read more: How rising inflation will affect your state pension It's the fourth consecutive increase in food inflation and the highest rate since February 2024. The ONS data showed that there were price rises for meat; sugar, jam, honey, syrups, chocolate and confectionery; coffee, tea and cocoa; and mineral waters, soft drinks and juices. Wholesale UK butter prices doubled compared to 2020. Jim Bligh, director of corporate affairs and packaging at the Food and Drink Federation (FDF), warned that' high food and drink inflation will persist through the year'. He said: "With high commodity prices, the new £1.4bn packaging tax, and increased national insurance costs, it's no surprise that many food and drink manufacturers have seen their costs increase by 10% or more this year. "Manufacturers have absorbed as many of these costs as possible, but consumers will still see higher prices at the till." Core inflation - which measures price rises without volatile food and energy costs - rose to 3.8%. Services inflation, a key measure of price pressures for the Bank of England, climbed to 5% in July from 4.7% in June. Air fares surged by 30.2% between June and July, the biggest jump since the collection of monthly data began in 2001. Prices across UK restaurants and hotels also increased last month, largely driven by a jump in overnight hotel stays booked the night before. In a statement from the Treasury on Wednesday morning, Chancellor Rachel Reeves said: 'We have taken the decisions needed to stabilise the public finances, and we're a long way from the double-digit inflation we saw under the previous government, but there's more to do to ease the cost of living. "That's why we've raised the minimum wage, extended the £3 bus fare cap, expanded free school meals to over half a million more children, and are rolling out free breakfast clubs for every child in the country. Through our Plan for Change we're going further and faster to put more money in people's pockets.' The data suggests rail fares are likely to rise by 5.8% next year. Increases in regulated train ticket prices are usually calculated by adding one percentage point to July's inflation reading as measured by the retail prices index, which was 4.8%. Pieter Reynders, a partner at McKinsey & Company, said: 'The CPI rise to 3.8% will sting households already under pressure. With the school summer holidays falling in July, and many families booking shorter holidays closer to home, transport [3.2%, showing the largest uptick vs June] and restaurant and hotel prices [3.4%], spiked. Some seasonal shifts are expected, but the pace of increases still far outstrips the Bank of England's 2% target. 'Food inflation further accelerated to 4.9%, above both CPI and wage growth at 4.6%. That means household budgets will continue to be squeezed, leaving only modest real income gains." Read more: How to find the weak link in your finances The figures complicate the picture for the Bank of England as policymakers decide whether they can cut interest rates again to boost the economy. Rate setters lowered borrowing costs from 4.25% to 4% earlier this month. 'The risk is that inflation expectations and wage growth rise further and the next move down in rates does not happen until next year,' said Ruth Gregory at Capital Economics. The BoE's target for inflation is 2%. Alice Haine, a personal finance analyst at Bestinvest by Evelyn Partners, said: "Mortgaged homeowners and first-time buyers may feel disheartened by the latest inflation reading. Rising inflation can dent affordability and reduce their borrowing power, making it harder to secure a mortgage or move up the property ladder. 'Rising inflation also puts a spanner in the works for those hoping for mortgage rates to ease more dramatically. Persistent price pressures may cause the central bank to delay further easing. While affordability has improved for buyers in recent months, thanks to lower mortgage rates and lenders relaxing their stress test rules, rates may not be easing as fast as people hoped."
Yahoo
8 minutes ago
- Yahoo
Medartis Holding AG (XSWX:MED) (Q2 2025) Earnings Call Highlights: Strong Revenue Growth and ...
This article first appeared on GuruFocus. Organic Revenue Growth: 15.3% in the first half of the year. Total Sales: CHF 123 million for the first half, including NeoOrtho consolidation from May. Core Gross Margin: Approximately 81%. Core EBITDA Margin: 17.8%. Core EBIT Margin: 8.5%. Cash Position: CHF 121 million at the end of June. EMEA Growth: 16% growth in the region. US Growth: 16.2% growth, with significant distributor changes. APAC Growth: 14.9%, driven by Japan and Australia. Latin America Performance: Improved but not meeting expectations; double-digit growth including NeoOrtho. Upper Extremities Growth: Driven by TOUCH and other product launches. CMF Growth: 10.3%, impacted by strong prior year performance. FX Impact: Over 300 basis points on top line, 50 basis points on gross margin. US Tariffs Impact: Estimated high single-digit million impact for 2026. Net Income: Slightly negative due to CHF 5.2 million unrealized FX losses. Guidance for Second Half: Raised to 14% to 16% growth, maintaining high teens core EBITDA margin. Warning! GuruFocus has detected 6 Warning Signs with XSWX:MED. Release Date: August 19, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Medartis Holding AG (XSWX:MED) reported an impressive organic revenue growth of 15.3% for the first half of the year, exceeding expectations. The integration of NeoOrtho is on track, with structural changes planned to consolidate teams and facilities in Brazil. The company has successfully completed the acquisition of KeriMedical, with plans to launch in the US market, supported by FDA readiness. Medartis has raised its guidance for the second half of the year to a 14% to 16% growth, reflecting a positive trend in sales. The company maintains a strong cash position with CHF121 million, ensuring financial flexibility for future investments and acquisitions. Negative Points The US tariffs of 39% are expected to have a significant impact, with a high single-digit million impact anticipated for 2026. The gross margin slightly decreased due to FX impacts and the inclusion of KeriMedical as a distributor, which initially diluted margins. The Latin America region, excluding NeoOrtho, showed underperformance, with growth not meeting expectations. The company faces challenges in the Japanese market, particularly in the upper extremity business, which requires attention. The impact of FX resulted in more than CHF5.2 million in unrealized non-cash losses, affecting the net income. Q & A Highlights Q: What impact do you expect from the optimization of the distributor networks on the US growth rate in the second half and in 2026? A: Matthias Schupp, CEO: The target of US growth above 20% is more for starting in 2026. For the second half, we expect growth above 16%, continuing faster than the first half. The changes in Florida, our biggest region, were unexpected but necessary for exclusivity, and we are confident in our raised guidance due to strong performance in July and August. Q: Could you clarify the expected gross margin of KeriMedical and how it affects the consolidated gross margin once fully integrated? A: Dirk Kirsten, CFO: KeriMedical's gross margin is accretive to our business. While NeoOrtho has a lower gross margin due to its value strategy, its EBITDA margin is accretive. We expect the overall impact on our consolidated gross margin to be positive. Q: Can you provide more details on the earn-out structure for the KeriMedical acquisition and the revenue potential for Keri TOUCH in the US during the initial years? A: Matthias Schupp, CEO: The earn-out is based on sales performance in the US for 2026 and 2027, and the reimbursement study is progressing well. We expect to capture at least 10% of the 150,000 procedures in the US by 2030, with a focus on education and careful market entry. Q: How did the Asia Pacific region achieve a 15% organic growth despite challenges in Australia and Japan? A: Matthias Schupp, CEO: Japan saw strong growth in CMF, doubling the business in the first half, and lower extremities also performed well. Australia exceeded expectations despite price cuts, and other APAC countries contributed through distribution channels. Q: What is the market penetration of Keri TOUCH in France, and what does this indicate for future growth? A: Matthias Schupp, CEO: In France, Keri TOUCH holds an 85% market share and continues to grow in the high teens. This success in France, the most mature market, indicates strong potential for growth in other regions as the product becomes the standard of care. For the complete transcript of the earnings call, please refer to the full earnings call transcript.